Pharma Industry Speeded-up in Production of COVID-19 Vaccines – Well, that’s Promising!

Tuesday, April 27, 2021 15:00 EST 2 mins read Source: NewsService

Pharma industry has put seamless efforts into the productivity of Covid-19 vaccines and continued to increase the productivity. Millions of Americans were vaccinated and continued to get the shots.

We should be incredibly proud of the pharma industry's role in fighting this pandemic. Simultaneously, our fight against COVID-19 has driven home a critical reality: We need to develop a better health care system that assures scientific advances are accessible and affordable to everyone who needs them.

Over 4 million Americans have taken Covid-19 Vaccine in Single Day!

As per Washington Post, over four million Americans have received the COVID-19 vaccine 2 weeks ago on Saturday — it is considered the largest single-day vaccination event in human history [1]. It takes years or decades of meticulous trial and error worth it for innovators across the pharmaceutical industry.

COVID-19 vaccines and treatments at Jet-speed

US government's unique research and development ecosystem allowed the Pharma Industry to develop COVID-19 vaccines and treatments at unparalleled speed. It’s time to preserve that ecosystem while enhancing our capability to respond to future public health emergencies immediately.

It all began with collaboration amongst biopharmaceutical companies, government agencies, and another public and private sector, significant in the nation's COVID-19 response. Future policy should avoid actions that would hinder this collaboration, such as the erosion of intellectual asset protections and reduced reasons for study and development.

What Led To Delays In Testings, Vaccines Distribution, And Various Other Trials?

Though the advancement of new vaccines and treatments occurred in record time, the pandemic also highlighted healthcare infrastructure weaknesses. These hurdles led to delays in testing, bottlenecks in the distribution of vaccines, and various other trials. The government has now proposed several policies that will help address these vulnerabilities and ensure that the health care system is more resilient for every future public health emergency.

Time to build a Non-Discriminatory Health Care System

The Covid-19 has made a significant impact on people belonging to different communities. The consequence has been disastrous because the living and working conditions made social distancing nearly impossible when the pandemic hit.

As responsible citizens, we should work on the following key points:

Eliminating the pandemic
Creating a more resilient system
Producing more effective & affordable medicines
Building a fair health care system

Today, voluntary policies adopted by the pharma industry to support more comprehensive clinical trial diversity will go into effect. As a country, the US will continue to examine fundamental changes in health care that would create more reasons for equitable access and outcomes.

As per the expert report, over 70 to 90 percent of the total US population — adults and children — needs to obtain resistance to the coronavirus to attain herd immunity; when transmission of the virus considerably slows by then, people would have been protected through vaccination.

REFERENCES:

[1] https://www.washingtonpost.com/nation/2021/04/05/coronavirus-covid-live-updates-us/

This content was first published by KISS PR Brand Story. Read here >> Pharma Industry Speeded-up in Production of COVID-19 Vaccines – Well, that’s Promising!